Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients

NCT05181046 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
420
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nanodropper, Inc.

Collaborators